Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.22.1
Stockholders' Equity (Tables)
 3 Months Ended
Mar. 31, 2022
Stockholders' Equity Note [Abstract]  
Schedule of stock-based compensation
    For the Three Months
Ended March 31,		  
    2022     2021  
Research and development   $ 28,808     $ 57,102  
General and administrative     427,615       263,342  
Total   $ 456,423     $ 320,444  

 
Schedule of stock option activity
                Weighted Average  
    Stock Options     Exercise Price     Fair Value     Contractual     Aggregate  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     Life (Years)     Intrinsic Value  
Balance – December 31, 2021     10,992,335       6,126,901     $ 1.71     $ 1.58     $ 1.58       6.27     $
-
  
Granted     375,000      
-
      
-
      
-
      
-
       -      
-
  
Exercised    
-
      
-
      
-
      
-
      
-
       -      
-
  
Cancelled     (30,208 )    
-
      
-
      
-
      
-
       -      
-
  
Balance – March 31, 2022     11,337,127       6,317,609     $ 1.67     $ 1.56     $ 1.56       6.27     $ 20,912  

 
Schedule of stock options outstanding and exercisable
Grant Price     Weighted
Average		  
   Total     Number     Weighted
Average
Remaining
Contractual
From     To     Exercise Price     Outstanding     Exercisable     Term
$ 0.26     $ 2.02     $ 1.17       8,356,377       3,149,818     7.83 years
$ 2.10     $ 4.60     $ 2.47       2,537,750       2,724,791     6.48 years
$ 5.30     $ 8.86     $ 6.44       443,000       443,000     6.10 years
                 
Totals
       11,337,127       6,317,609      

   
Schedule of warrants activity
                Weighted Average        
    Warrants     Exercise Price     Fair Value     Contractual
Life		     Aggregate
Intrinsic		  
    Outstanding     Exercisable     Outstanding     Exercisable     Vested     (Years)     Value  
Balance – December 31, 2021     35,634,075       35,629,908     $ 1.04     $ 1.04     $ 0.53       4.38     $
-
  
Granted    
-
      
-
      
-
      
-
      
-
       -      
-
  
Exercised    
-
      
-
      
-
      
-
      
-
       -      
-
  
Cancelled     (159,000 )    
-
      
-
      
-
      
-
       -      
-
  
Balance – March 31, 2022     35,475,075       35,475,075     $ 1.03     $ 1.03     $ 0.61       4.15     $ 43,042